Blue Jet Healthcare Limited has scheduled a Board of Directors meeting on May 25, 2026. The board will review and approve the company’s audited standalone financial results for the quarter and financial year ended March 31, 2026. Additionally, directors will consider a proposal for a potential final dividend payout and discuss strategies for raising funds through various permissible methods, including preferential issues or qualified institutional placements to support future growth.
Upcoming Board Meeting Details
Blue Jet Healthcare Limited has announced that a meeting of its Board of Directors is set for Monday, May 25, 2026. The primary agenda for this meeting involves the formal review and approval of the audited financial performance for the quarter and the full financial year ending March 31, 2026, alongside the associated audit reports.
Dividend and Strategic Fundraising
During the session, the board will evaluate a recommendation for a final dividend on equity shares for the fiscal year 2025-26. Any declaration of dividends will be subject to approval by shareholders at the company’s upcoming Annual General Meeting.
Furthermore, the board will deliberate on a proposal to raise capital. The company is considering multiple financial instruments, such as preferential issues or qualified institutions placement, as part of its strategy to bolster its financial position. These proposals will be subject to necessary regulatory and shareholder approvals.
Trading Window Update
In accordance with internal corporate governance policies, the company’s trading window remains closed for all designated persons and their immediate relatives. The window will reopen 48 hours after the financial results are declared, effective from Thursday, May 28, 2026.
Source: BSE
